CAS 2134602-45-0|≥99% Purity by HPLC|ISO 17025 Analytical Verification

Product Spec Sheet

SR-17018 · CAS 2134602-45-0 · Rev 1.2 · 2026-01-20

Two-page product specification suitable for attachment to grant protocols, procurement requests, and institutional purchasing documentation.

Download Spec Sheet (PDF)

Document Contents

Product Identity

  • Name, CAS number, molecular formula, and molecular weight
  • Structural diagram and SMILES string
  • InChIKey and synonyms

Analytical Specifications

  • Purity by HPLC-UV (acceptance criterion ≥99.0%)
  • Identity by LC-MS/MS (m/z and key fragment ions)
  • Structural confirmation by ¹H-NMR
  • Moisture content by Karl Fischer (acceptance criterion ≤1.0% w/w)

Biological Activity Summary

  • Target: μ-opioid receptor (MOR)
  • Mechanism: G-protein-biased agonist, reduced β-arrestin-2 recruitment
  • Selectivity profile: MOR vs. DOR and KOR

Storage Requirements

  • Temperature: −20 °C
  • Atmosphere: inert (argon or nitrogen)
  • Desiccation: required
  • Light: protect from light
  • Shelf life: ≥24 months from manufacture date under recommended conditions

Documentation References

  • Certificate of Analysis — current batch
  • Safety Data Sheet — current version
  • Analytical methods summary

Revision History

RevisionDateChange Notes
Rev 1.02025-03-01Initial release.
Rev 1.12025-08-15Added ¹H-NMR spectral data and diagnostic peak assignments.
Rev 1.22026-01-20Updated stability data based on 12-month real-time stability study results.